182 related articles for article (PubMed ID: 6542470)
21. Assessment of 5 alpha-reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretion.
Gilad S; Chayen R; Tordjman K; Kisch E; Stern N
Clin Endocrinol (Oxf); 1994 Apr; 40(4):459-64. PubMed ID: 8187312
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women.
Miles RA; Cassidenti DL; Carmina E; Gentzschein E; Stanczyk FZ; Lobo RA
Fertil Steril; 1992 Oct; 58(4):708-12. PubMed ID: 1426314
[TBL] [Abstract][Full Text] [Related]
23. Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women.
Fruzzetti F; de Lorenzo D; Parrini D; Ricci C
J Clin Endocrinol Metab; 1994 Sep; 79(3):831-5. PubMed ID: 8077369
[TBL] [Abstract][Full Text] [Related]
24. Metabolism of dihydrotestosterone to 5 alpha-androstane-3 alpha, 17 beta-diol glucuronide is greater in the peripheral compartment than in the splanchnic compartment.
Duffy DM; Legro RS; Chang L; Stanczyk FZ; Lobo RA
Fertil Steril; 1995 Oct; 64(4):736-9. PubMed ID: 7672144
[TBL] [Abstract][Full Text] [Related]
25. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
[TBL] [Abstract][Full Text] [Related]
26. Androgens in hirsute women referred for electroepilation.
Fogh H; Worm AM; Forkert B; Bennett P
Acta Derm Venereol; 1989; 69(2):179-82. PubMed ID: 2564241
[TBL] [Abstract][Full Text] [Related]
27. Is 3 alpha-androstanediol a marker of peripheral hirsutism?
Toscano V; Sciarra F; Adamo MV; Petrangeli E; Foli S; Caiola S; Conti C
Acta Endocrinol (Copenh); 1982 Feb; 99(2):314-20. PubMed ID: 6460409
[TBL] [Abstract][Full Text] [Related]
28. Serum C-19 steroid sulphates in females with clinical hyperandrogenism.
Montalo J; Funder JW; Yong AB; Callan A; Davies HE; Connelly JF
J Steroid Biochem; 1989; 34(1-6):531-4. PubMed ID: 2533951
[TBL] [Abstract][Full Text] [Related]
29. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
Frölich M; Lachinsky N; Moolenaar AJ
Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
[TBL] [Abstract][Full Text] [Related]
30. Role of androgens in menstrual disorders of nonhirsute and hirsute women, and the effect of glucocorticoid therapy on androgen levels in hirsute hyperandrogenic women.
Ho Yuen B; Mincey EK
Am J Obstet Gynecol; 1983 Jan; 145(2):152-7. PubMed ID: 6401396
[TBL] [Abstract][Full Text] [Related]
31. Serum testosterone, dihydrotestosterone and sex hormone binding globulin (SHBG) in girls with hirsutism and menstrual disturbances).
Szamatowicz M; Kulikowski M
Endokrinologie; 1979 Feb; 73(1):20-6. PubMed ID: 572765
[TBL] [Abstract][Full Text] [Related]
32. Should androgen levels be measured in hirsute women with normal menstrual cycles?
Mehta A; Matwijiw I; Taylor PJ; Salamon EA; Kredentser JV; Faiman C
Int J Fertil; 1992; 37(6):354-7. PubMed ID: 1360456
[TBL] [Abstract][Full Text] [Related]
33. Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women.
Carmina E; Stanczyk FZ; Matteri RK; Lobo RA
Fertil Steril; 1991 May; 55(5):872-6. PubMed ID: 1827073
[TBL] [Abstract][Full Text] [Related]
34. Plasma androgen concentrations in diabetic women.
Szpunar WE; Blair AJ; McCann DS
Diabetes; 1977 Dec; 26(12):1125-9. PubMed ID: 145387
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
Meczekalski B; Slopien R; Warenik-Szymankiewicz A
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
[TBL] [Abstract][Full Text] [Related]
36. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
Carmina E; Lobo RA
Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
[TBL] [Abstract][Full Text] [Related]
37. Ovarian and adrenal contributions to peripheral androgens in hirsute women.
Abraham GE; Chakmakjian ZH; Buster JE; Marshall JR
Obstet Gynecol; 1975 Aug; 46(2):169-73. PubMed ID: 125398
[TBL] [Abstract][Full Text] [Related]
38. Serum androstanediol glucuronide in women with facial hirsutism.
Salman K; Spielvogel RL; Shulman LH; Miller JL; Vanderlinde RE; Rose LI
J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):411-4. PubMed ID: 1564146
[TBL] [Abstract][Full Text] [Related]
39. Plasma C19 steroid sulphate levels and indices of androgen bioavailability in female pattern androgenic alopecia.
Montalto J; Whorwood CB; Funder JW; Yong AB; Callan A; Davies HE; Connelly JF
Clin Endocrinol (Oxf); 1990 Jan; 32(1):1-12. PubMed ID: 2139595
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of idiopathic hirsutism.
Carmina E
Eur J Endocrinol; 1998 Oct; 139(4):421-3. PubMed ID: 9820619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
